The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 5, p. 253, doi. 10.1177/2040620715596715
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2015 AND VI 6 AND IP 5
Results: 4
1
2
Ibrutinib in mantle cell lymphoma patients: glass half full? Evidence and opinion.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 5, p. 242, doi. 10.1177/2040620715592569
- By:
- Publication type:
- Article
3
Demographic and other characteristics of nodal non-Hodgkin's lymphoma managed in academic versus non-academic centers.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 5, p. 223, doi. 10.1177/2040620715592568
- By:
- Publication type:
- Article
4
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL).
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 5, p. 228, doi. 10.1177/2040620715588916
- By:
- Publication type:
- Article